Adirondack Cancer Center is a clinical research site located in Glens Falls, New York, United States 12801.
Crixeo Clinical Trials Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Adirondack Cancer Center has participated in 13 clinical trials with 3 currently active.
Therapeutic areas: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.
Sponsors: National Cancer Institute (NCI), ETOP IBCSG Partners Foundation.
Trust Score: 71/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Adirondack Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Adirondack Cancer Center has 13 clinical trials on record, with 3 currently active. Their work covers Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma.
Adirondack Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.